PET/MR

Expanding the Reach of Care for Cancer and Other Disease States: BAMF Health and GE HealthCare collaborate to enable sustainable and scalable solutions for growth in Theranostics

Retrieved on: 
Monday, November 13, 2023
Other Health, Software, General Health, Pharmaceutical, Oncology, Technology, Infectious Diseases, Hospitals, Artificial Intelligence, Health Technology, Other Technology, Health, BAMF, PET/CT, SPECT/CT, PET/MR, Patient, Multimedia, Alzheimer's disease, Molecular imaging, Cyclotron, Cancer, Drug development, GE HealthCare, Medical imaging, Personalized medicine

As demand for Theranostic care increases, GE HealthCare and BAMF Health are excited to announce a collaboration aimed at enabling BAMF Health to scale turnkey offerings inclusive of leading GE HealthCare technologies and services.

Key Points: 
  • As demand for Theranostic care increases, GE HealthCare and BAMF Health are excited to announce a collaboration aimed at enabling BAMF Health to scale turnkey offerings inclusive of leading GE HealthCare technologies and services.
  • The goal of the collaboration is to ensure an agile go-to-market approach to enhance the adoption of Theranostics solutions in the U.S.
  • The arrangement supports a shared interest in better patient outcomes made possible through advanced diagnostics and radiotherapeutics.
  • The collaboration between GE HealthCare and BAMF Health will leverage both partners’ deep understanding of the complexities of delivering Theranostic care to establish a framework to support the scalable infrastructure and clinical solutions for expanded adoption of precision care.

ConcertAI's TeraRecon Adds Mirada Medical to its AI Partner Program and Comprehensive Oncology Imaging Solutions

Retrieved on: 
Wednesday, August 2, 2023
Table, Intuition, Physician, Cancer, Patient, PET/CT, PET/MR, Diagnosis, AI, Automation, Medical imaging

CAMBRIDGE, Mass., Aug. 2, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today the integration of MiradaXD, the multi-modality nuclear medicine imaging software by Mirada Medical, into its AI partner program.

Key Points: 
  • CAMBRIDGE, Mass., Aug. 2, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today the integration of MiradaXD, the multi-modality nuclear medicine imaging software by Mirada Medical, into its AI partner program.
  • This expands its ability to support cancer care providers with comprehensive oncology imaging solutions.
  • Mirada Medical's innovative software solutions, developed by world-leading experts in medical imaging, address a range of cancer-related challenges, from the automation of tumor segmentation and tracking to personalized treatment planning and response assessment.
  • "We are thrilled to partner with TeraRecon to bring our solutions to a wider audience of cancer care providers," said Jon DeVries, CEO of Mirada Medical.

GE HealthCare Advances PET/MR Capabilities with AIR Technologies

Retrieved on: 
Friday, June 23, 2023
Oncology, Medical Devices, FDA, Health, Health Technology, Radiology, GE HealthCare, Society, SNMMI, Disease, PSMA, Molecular imaging, Deep learning, Society of Nuclear Medicine and Molecular Imaging, Cancer, GE, PET, Multimedia, Movement, Sale, Time of flight, MRI, Motion, HIV disease progression rates, Patient, AIR, Prostate cancer, PET/MR, Diagnosis, Alzheimer's disease, World Health Organization, Medical imaging, Pharmaceutical industry

The company will showcase the integration of its advanced AIR technologies with the SIGNA PET/MR AIR system, to enhance diagnostic precision, simplify treatment evaluation, while elevating patient comfort.

Key Points: 
  • The company will showcase the integration of its advanced AIR technologies with the SIGNA PET/MR AIR system, to enhance diagnostic precision, simplify treatment evaluation, while elevating patient comfort.
  • The unique AIR technologies from GE HealthCare incorporated into SIGNA PET/MR AIR address the evolving demands of these patient populations.
  • These technologies include AIR Coils, which enhance and improve patient comfort, AIR Recon DL, which improves MR image quality and enables scan time reduction, and MotionFree Brainii, which mitigates motion-related PET image degradation.
  • "The SIGNA PET/MR AIR system continues our legacy of delivering innovative technologies that address a comprehensive range of clinical diseases,” said Jie Xue, President and CEO of MR at GE HealthCare.

United Imaging Unveils a Full Portfolio of Products at CMEF 2023, Highlighting Its AI Capabilities across Modalities

Retrieved on: 
Wednesday, May 17, 2023
Yale University, Blockchain, University, Moses Austin, Freedom, MI, Dow International Medical College, 3D, UDP, Research, Multimedia, MR, DSA, Washington University in St. Louis, 2D, Movement, Umi, Radiation, Hospital, LINAC, Neurosurgery, Scan, ACS, Patient safety, PET/CT, PET/MR, Neoplasm, AI, RT, AR, ASIC, Medical imaging, Medical device

SHANGHAI, May 17, 2023 /PRNewswire/ -- United Imaging unveiled its full range of products, including PET/CT, PET/MR, MR, CT, DR, RT, and digital solutions, at the China International Medical Equipment Fair (CMEF) recently, highlighting the products' AI capacity across modalities.

Key Points: 
  • SHANGHAI, May 17, 2023 /PRNewswire/ -- United Imaging unveiled its full range of products, including PET/CT, PET/MR, MR, CT, DR, RT, and digital solutions, at the China International Medical Equipment Fair (CMEF) recently, highlighting the products' AI capacity across modalities.
  • Many of the offerings incorporated AI capabilities, which are designed to provide clinicians with more accurate and efficient tools for diagnosing and treating a variety of clinical scenarios.
  • One standout product was the uRT-linac 506c, an innovative medical linear accelerator (LINAC) device from United Imaging.
  • Moving forward, United Imaging Group will leverage the power of our super innovation cluster to expand beyond imaging and promote integration within medical treatment.

U.S PET Imaging Market Summary Report 2023: PET Prostate Scan Volumes Saw Robust Growth in 2022 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 6, 2023
Radiology, Health, Medical Devices, GE HealthCare, F-18 FDG, CT, Bed, Original equipment manufacturer, Cancer, GE, PET, Radiopharmaceutical, Cardinal Health, Siemens Healthineers, Hospital, Patient, Canon Medical Systems Corporation, PET/CT, PET/MR, Diagnosis, Philips, Cardiology, OEM, Neurology, Medical imaging, Jubilant

This '2023 PET Imaging Market Summary Report' summarizes the results from the Medical Information Division's 2022 PET Census of hospital and non-hospital facilities performing PET imaging in the United States.

Key Points: 
  • This '2023 PET Imaging Market Summary Report' summarizes the results from the Medical Information Division's 2022 PET Census of hospital and non-hospital facilities performing PET imaging in the United States.
  • PET prostate scan volumes grew 46% year-over-year, showing an increase of 3 percentage points to produce 9% of the overall procedure mix by study type, according to the 2023 PET Market Summary Report.
  • After a 12.2% increase in overall PET scan volume in 2021, PET scan volume remained flat year over year in 2022.
  • The '2023 PET Imaging Market Summary Report' monitors trends in PET scan utilization, the adoption of fixed PET scanners (e.g., PET-only, PET/CT, and PET/MR), the use of mobile PET services, purchase plans, and radiopharmaceutical use.

United Imaging Healthcare unveils the world's first whole-body ultra-high field 5.0T MRI, uMR Jupiter 5.0T, at ECR

Retrieved on: 
Thursday, March 2, 2023
2D, Yale University, CT, MRI, FDA, ACS, AI, Cycle, Research, Poison Ivy: Cycle of Life and Death, University, Workflow, UMR, 3D, ECR, European Society of Radiology, Patient, Health, PET/MR, Marketing, International business, Acceleration, PET/CT, Radiation, SNR, Medicine, Washington University in St. Louis, United Arab Emirates, Moses Austin, Impossible, Hospital, Medical imaging, Medical device, Radiology

VIENNA, March 2, 2023 /PRNewswire/ -- The world's first whole-body ultra-high field 5.0T MRI, the uMR Jupiter 5.0T, was unveiled for the first time internationally along with United Imaging Healthcare's comprehensive flagship products across all modalities, including PET/CT, PET/MR, MR, CT, and DR, at the European Society of Radiology (ECR) on March 1–5 in Vienna, Austria.

Key Points: 
  • Furthermore, the innovative 5.0T magnet could be installed in a 3.0T-sized room, making it more accessible to healthcare professionals.
  • Potentially, the uMR Jupiter 5.0T will break new ground in precision medicine, translational medicine, and beyond.
  • "United Imaging, a global innovator in cutting-edge medical imaging and radiotherapy equipment, is certain that medical imaging can improve people's lives.
  • So far, United Imaging has launched over 90 groundbreaking products, with core technologies developed in-house, that are globally recognized for world-leading performance.

Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care

Retrieved on: 
Thursday, June 9, 2022
FDA, Other Health, Technology, Radiology, Pharmaceutical, Oncology, Hospitals, Men, Other Technology, Biotechnology, Science, Alternative Medicine, Other Science, Consumer, Research, Health, Molecule, Radioligand, SNMMI, Time, University of Michigan, CZT, College of Arts and Sciences, Associate, SNR, Organic, Sale, CT, Technology, NYSE, COVID-19, Research, Molecular imaging, Radiopharmaceutical, Nuclear medicine, Cyclotron, News, CEO, CE, Ecosystem, Solution, Artificial intelligence, Federal Food, Drug, and Cosmetic Act, Health, Thomas Edison, Diagnosis, PET/CT, Industry, Radiation, Collection, WEHR, Patient, GE Healthcare, PET/MR, World Health Organization, Noise, Prostate cancer, PET-CT, Radionuclide, University, Physician, Efficiency, Discovery, NEMA, SPECT, PET, Prostate Cancer Foundation, PSMA, Man, LinkedIn, Disease, FDA, FOV, Biology, Risk, Society of Nuclear Medicine and Molecular Imaging, Twitter, CT scan, Medical imaging, Pharmaceutical industry, Medical device, Palladium, Cancer, Radiology, Gallium, Facebook

GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer the most prevalent cancer in men and the third most prevalent cancer overalli.

Key Points: 
  • GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer the most prevalent cancer in men and the third most prevalent cancer overalli.
  • Healthcare is timely and personal and its delivery should be too, explains Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE Healthcare.
  • To prepare for the creation of dedicated theranostics centers, SNMMI and related international molecular imaging societies recently published a new guide for healthcare systems globallyiii.
  • As the industry prepares to usher in this new era of precision health and personalized medicine, GE Healthcare is proud to offer innovative molecular imaging solutions to healthcare systems around the world.

United Imaging Announces Construction of a World-leading Intelligent R&D and Manufacturing Complex with an Investment of More Than USD 490 million

Retrieved on: 
Thursday, January 13, 2022
Gensler, Nature, Research, Technology, IOT, Human, Shanghai Tower, R, RT, River, PET/MR, PET/CT, CEO, Multimedia, AI, USD, Medical device

It was designed by Gensler, a top global architectural design company that once designed the Shanghai Tower, the world's 3rd tallest building.

Key Points: 
  • It was designed by Gensler, a top global architectural design company that once designed the Shanghai Tower, the world's 3rd tallest building.
  • Dr. Xue Min, Chairman of United Imaging Group, highlighted, "The new complex will forge United Imaging as a world-leading, modern, intelligent, medical equipment R&D and manufacturing leader.
  • With this great headway, United Imaging will largely boost its R&D and production capabilities and research abilities as a future-oriented enterprise."
  • The new complex will also include a digital, intelligent super factory to promote automatic and intelligent manufacturing.

United Imaging Blazes a Trail, Helping Customers "Future Proof"

Retrieved on: 
Monday, November 29, 2021
CEO, Memorial Sloan Kettering Cancer Center, Technology, Industry, Radiation, PET/MR, Radiology, Workflow, Solution, Health, Software Upgrade Protocol, ATLAS, PSMA, Life, Medical imaging, Online shopping

What impact do extra processes, wasteful steps, and a lack of standardization have on consistency in practice, and how can variability be reduced?

Key Points: 
  • What impact do extra processes, wasteful steps, and a lack of standardization have on consistency in practice, and how can variability be reduced?
  • United Imaging is offering this symposium as part of a broader theme on "future-proofing," and how they help imaging providers grow, innovate, and get better investment protection for their equipment purchases.
  • At United Imaging, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment.
  • With a cutting-edge digital portfolio and a mission of broader access to healthcare for all, we help drive industry progress and bold change.

Bruker Announces Acquisition of MOLECUBES NV

Retrieved on: 
Friday, November 19, 2021
Manufacturing, Other Health, Technology, Pharmaceutical, General Health, Hospitals, Clinical Trials, Other Technology, Other Manufacturing, Science, Biotechnology, Software, Other Science, Health, Research, Adoption, CEO, Data analysis, Technology, SPECT, Acquisition, Proteomics, Microscopy, PET/MR, Bruker, Solution, Molecular imaging, NMI, Software, Nasdaq, Research, Corporation, X-ray, PET, Academic health science centre, CT, Multimedia, Cell biology, Life, Drug discovery, Medical imaging, Pharmaceutical industry, Bruker Corporation (Nasdaq: BRKR), MOLECUBES, BRUKER CORPORATION (NASDAQ: BRKR), MOLECUBES

Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV , a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV , a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems.
  • This acquisition strengthens Brukers position as a leading NMI solutions provider in preclinical and translational imaging research.
  • The acquisition of MOLECUBES adds scalable benchtop instruments to our portfolio for serving the NMI preclinical research community.
  • MOLECUBES will remain an innovative and agile operational team within the Bruker BioSpin Preclinical Imaging division, and MOLECUBES customers can continue communications through existing channels.